Home Cart Sign in  
Chemical Structure| 1245916-14-6 Chemical Structure| 1245916-14-6

Structure of Alirocumab
CAS No.: 1245916-14-6

Chemical Structure| 1245916-14-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Alirocumab (anti-PCSK9) is a human monoclonal antibody that specifically binds to PCSK9, a downregulator of hepatic low-density lipoprotein (LDL) receptors. It increases the liver's ability to bind LDL-cholesterol (LDL-C) and reduces blood LDL-C levels. Alirocumab can be used in hypercholesterolemia research.

Synonyms: REGN 727; SAR 236553

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Alirocumab

CAS No. :1245916-14-6
M.W : 146.24 kDa
SMILES Code : NONE
Synonyms :
REGN 727; SAR 236553
MDL No. :N/A

Safety of Alirocumab

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT06083961 Stroke, Acute Ischemic|PCSK9 I... More >>nhibitor Less << PHASE4 NOT_YET_RECRUITING 2026-11-15 Asan Medical Center, Seoul, 13... More >>8-736, Korea, Republic of Less <<
NCT03067844 Coronary Vessel|Coronary Circu... More >>lation|Atheroma; Myocardial Less << PHASE3 COMPLETED 2021-10-13 University Hospital Vienna (AK... More >>H), Wien, 1090, Austria|Rigshospitalet, Copenhagen, 2100, Denmark|Radboud Univerity, Nijmegen Medical Centre, Nijmegen, Gelderland, 6525, Netherlands|Erasmus Thoraxcentre, Rotterdam, 3015, Netherlands|Basel University Hospital, Basel, 4031, Switzerland|Bern University Hospital Inselspital, Bern, 3010, Switzerland|Hopitaux Universitaires Geneve, Geneva, 1211, Switzerland|Stadtspital Triemli, Zurich, 8063, Switzerland|University Hospital Zurich USZ, Zürich, 8091, Switzerland Less <<
NCT05001984 Intracranial Atherosclerosis|A... More >>cute Ischemic Stroke|ICAS - Intracranial Atherosclerosis Less << PHASE2 RECRUITING 2024-12-31 Yenchu Huang, Chiayi City, 613... More >>, Taiwan Less <<
NCT03533959 Coronary Artery Disease Progre... More >>ssion Less << RECRUITING 2025-12-25 Kobe University Graduate Schoo... More >>l of Medicine, Department of Cardiology, Kobe, Hyogo, 650-0017, Japan Less <<
NCT05465278 Familial Hypercholesterolemia PHASE4 COMPLETED 2022-03-30 Fundacion Hipercolesterolemia ... More >>Familiar, Madrid, 28010, Spain Less <<
NCT02992301 Atherosclerosis|Hyperlipidemia PHASE4 UNKNOWN 2025-11-19 Westside Medical Associates of... More >> Los Angeles, Beverly Hills, California, 90211, United States Less <<
NCT03552432 Coronary Artery Disease|Thin-c... More >>ap fIbroatheroma Less << PHASE4 UNKNOWN 2021-09-30 Kobe University Graduate Schoo... More >>l of Medicine, Department of Cardiology, Kobe, Hyogo, 650-0017, Japan Less <<
 

Historical Records

Categories